Jena, Germany

Birgit Schneider

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Jenapharm Gmbh & Co. Kg. Active years: 2002.


% Patents Active = 100.0


Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Birgit Schneider: Innovator in Pharmaceutical Chemistry

Introduction

Birgit Schneider is a notable inventor based in Jena, Germany. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patent work. His expertise and dedication have led to advancements in the development of pharmaceutical preparations.

Latest Patents

Birgit Schneider holds a patent for "S-substitute 11&bgr;-benzaldoxime-estra-4, 9-diene-carbonic acid thiolesters, method for the production thereof and pharmaceutical preparations containing these compounds." This patent showcases his ability to create novel compounds that have potential applications in medicine.

Career Highlights

Throughout his career, Birgit Schneider has worked with prominent companies in the pharmaceutical industry. He has been associated with Jenapharm GmbH & Co. KG and Bayer Schering Pharma AG. His work in these organizations has allowed him to apply his innovative ideas in practical settings, contributing to the development of new therapies.

Collaborations

Birgit Schneider has collaborated with esteemed colleagues, including Guenther Kaufmann and Gerd Schubert. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise in the field of pharmaceutical research.

Conclusion

Birgit Schneider's contributions to pharmaceutical chemistry through his patent and collaborations highlight his role as an influential inventor. His work continues to impact the industry positively, paving the way for future innovations in medicine.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…